Many patients with chronic inflammatory diseases have access to therapies that only relieve their symptoms. We believe we can address the root cause of these debilitating diseases by treating it at the molecular level.
Disease Education Information: Inflammation
Inflammation is a critical response to potential danger signals and damage to organs in our body. But with autoimmune diseases such as rheumatoid arthritis, lupus, ulcerative colitis, Crohn’s disease, and many others, our own immune system turns against our organs.
These painful and debilitating conditions take an immense toll on people’s quality of life and many of these diseases are poorly managed by existing treatments that provide only symptomatic relief.
For decades, doctors relied on steroids to suppress immune response. Though an important option, steroids come with many potentially harmful side effects.
Fortunately, science has continued to advance, and today we have the opportunity to transform the management of inflammatory diseases with new classes of therapies that target other key proteins and pathways in the body.
Inflammation & Immunology Resources
The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.
Our Centers for Therapeutic Innovation collaborates with academic institutions and investigators to push forward great science, using the depth and breadth of the Pfizer enterprise to accelerate concepts into viable therapies with breakthrough potential for patients.
We’re developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with obesity, type 2 diabetes, and cardiovascular and kidney diseases.
We look for treatments that provide more than just symptom relief, in order to address the root cause of chronic inflammatory diseases at a molecular level
Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal.
Anti-infectives are medicines that work to prevent or treat infections, including antibacterials, antivirals, antifungals, and antiparasitic medications.
The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.
Meet the people behind our medicines. Our experts make discoveries that give the world cutting-edge treatments for conditions that span the range from the common cold to rare diseases.